Adam J. Adler

Arthritis and Clinical Immunology, oklahoma medical research foundation

Affiliated withoklahoma medical research foundation

Research Area

Biography

Adam J. Adler has not added Biography.
If you are Adam J. Adler and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 15	2013

Other Publications

Article	Year
CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12023353	2002
Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12244153	2002
CD4+ T cells pass through an effector phase during the process of in vivo tolerance induction. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12682221	2003
Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentials. Cellular immunology\| PubMed ID: 14609577	2003
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15100273	2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15128793	2004
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen. Cancer cell\| PubMed ID: 15766662	2005
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16393991	2006
Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis and rheumatism\| PubMed ID: 16868974	2006
Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16982857	2006
Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis. The Prostate\| PubMed ID: 17221844	2007
Mechanisms of T cell tolerance and suppression in cancer mediated by tumor-associated antigens and hormones. Current cancer drug targets\| PubMed ID: 17305474	2007
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17641018	2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17947638	2007
The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death. Journal of leukocyte biology\| PubMed ID: 18923104	2009
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19017962	2008
In vitro and in vivo differentiated effector CD8 T cells display divergent histone acetylation patterns within the Ifng locus. Immunology letters\| PubMed ID: 19195486	2009
The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19801520	2009
Blood feeding by the Rocky Mountain spotted fever vector, Dermacentor andersoni, induces interleukin-4 expression by cognate antigen responding CD4+ T cells. Parasites & vectors\| PubMed ID: 19814808	2009
Tc17 CD8 T cells: functional plasticity and subset diversity. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19917680	2009
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity. Current immunology reviews\| PubMed ID: 20411047	2005
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21880986	2011
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. American journal of human genetics\| PubMed ID: 22464253	2012
Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22689946	2012
Two independent functional risk haplotypes in TNIP1 are associated with systemic lupus erythematosus. Arthritis and rheumatism\| PubMed ID: 22833143	2012
Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood\| PubMed ID: 22993390	2012
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion. Immunology and cell biology\| PubMed ID: 23295363	2013
Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation. Oncoimmunology\| PubMed ID: 23482891	2013
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature genetics\| PubMed ID: 24097067	2013